Cogent Biosciences, Inc. (COGT) vs Kiniksa Pharmaceuticals International, plc (KNSA)
A side-by-side comparison of Cogent Biosciences, Inc. and Kiniksa Pharmaceuticals International, plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$30.03HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
KNSA
Kiniksa Pharmaceuticals International, plc
$74.09HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — COGT vs KNSA
growth of $100 · dividends reinvested · last 8yCOGT -32.7% (-4.8%/yr)KNSA +291.9% (+18.6%/yr)KNSA compounded faster over this window
Log scale — wide-divergence pair
COGT KNSA
COGT vs KNSA: by the numbers
- •KNSA is the larger company ($5.65B vs $5.13B market cap).
- •KNSA is profitable (9.59% net margin) while COGT runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | COGT | KNSA |
|---|---|---|
| P/E ratio | N/A | 75.60 |
| Forward P/E | N/A | 53.20 |
| P/S ratio | N/A | 6.71 |
| P/B ratio | 10.97 | 8.63 |
| EV / EBITDA | N/A | 53.70 |
| FCF yield | N/A | 3.24% |
Profitability
| Metric | COGT | KNSA |
|---|---|---|
| Gross margin | 0.00% | 54.49% |
| Operating margin | 0.00% | 11.92% |
| Net margin | 0.00% | 9.59% |
| ROE | -70.85% | 12.33% |
| ROIC | -50.09% | 9.76% |
Growth (annualized)
| Metric | COGT | KNSA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 155.66% |
| Total return CAGR (5Y) | 28.51% | 47.48% |
Frequently asked
- Is COGT or KNSA more profitable?
- KNSA runs the higher net margin — COGT at 0.00% versus KNSA at 9.59%.
- How have COGT and KNSA total returns compared?
- Over the past 5 years, COGT delivered 28.51% and KNSA delivered 47.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Kiniksa Pharmaceuticals International P/E ratioCogent Biosciences ROEKiniksa Pharmaceuticals International ROECogent Biosciences operating marginKiniksa Pharmaceuticals International operating marginCogent Biosciences revenue growthKiniksa Pharmaceuticals International revenue growthCogent Biosciences free cash flowKiniksa Pharmaceuticals International free cash flow
Cogent Biosciences & Kiniksa Pharmaceuticals International appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.